Center for Cellular Metabolism Research in Oklahoma
Center for Cellular Metabolism Research in Oklahoma
批准号:
10853688
负责人:
Lijun Xia
金额:
$57.17万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-02-05 至 2024-01-31
关键词:
AcetylationAction PotentialsAreaArrhythmiaAwardBiological AssayBlood VesselsCalciumCalcium SignalingCardiacCardiac MyocytesCellsCenters of Research ExcellenceCollaborationsComplexConsciousCouplingDataDefectDelawareDiabetes MellitusDisease ProgressionEFRACElectrocardiogramEventFibroblastsFoundationsFunctional disorderGenesGeometryGlucoseGoalsGrantHeartHeart AtriumHeart DiseasesHeart failureImpairmentIncidenceIsoproterenolKineticsLaboratoriesLaboratory StudyLeftLinkLipidsMalignant - descriptorMapsMeasuresMedicalMetabolicMetabolismMitochondriaMolecularMorphologyMusNeuronsObesityOklahomaOsmosisOxidation-ReductionParentsPatientsPatternPerfusionPhenotypePilot ProjectsPredispositionProteinsPumpResearchResearch Project GrantsResearch SupportResourcesRiskRisk FactorsRoleSedation procedureSeriesSignal TransductionSodium-Calcium ExchangerStressStress TestsStrokeSudden DeathSurfaceSystemTelemetryTestingTissuesTrainingTranscriptUniversitiesVentricularVentricular Arrhythmiaaqueouscalmodulin-dependent protein kinase IIcell typecellular targetingdesigndiabetic cardiomyopathyexperienceexperimental studyheart metabolismhypertensivein vivoinduced pluripotent stem celllive cell imagingmetabolic phenotypemetabolomicsmitochondrial dysfunctionmitochondrial metabolismmouse modelnew therapeutic targetnovelprogramssudden cardiac deathtranscriptomicsuptake
中文摘要
母公司Cobre奖(P20GM139763)的目标是支持研究项目负责人(RPL)
在科布雷的领导下,通过创造和统一资源,在细胞代谢领域实现科学独立--
俄克拉荷马州细胞代谢研究支持中心(CMRO)。李志峰医生一直被
由CMRO-Cobre作为RPL支持。李实验室创建了一个研究项目,调查
新陈代谢如何调节心脏病的进展。在目前Cobre的支持下,Lee实验室
探讨线粒体功能障碍和NAD+氧化还原失衡促进糖尿病的机制
心肌病。心脏病患者与心律失常有关,心律失常会增加患者的风险。
心力衰竭、中风和猝死。在这项补充奖中,李实验室寻求支持,以继续
与特拉华大学LAM实验室在心脏电/钙信号方面的合作,并
一起研究线粒体功能障碍和代谢在心律失常发生中的机制作用。
我们的目标是研究线粒体新陈代谢如何调节电/钙信号以促进
心律失常,这一假说还没有得到严格和直接的检验。林志强医生训练有素
在实验室研究小鼠模型中的电/钙信号并使用诱导的多能干细胞
用于识别心律失常机制的平台。我们的试点数据使用心脏特有的线粒体
功能障碍小鼠(Ndufs4-CKO)显示线粒体功能障碍增加了心脏对
导致心律失常并促进猝死。我们发现在分离的心肌细胞中钙信号会发生改变
来自心律失常的Ndufs4-CKO心脏。在这个增刊奖中,我们计划彻底描述变化的特征
在这些心律失常的心脏中,线粒体的功能和代谢,以及电/钙信号。
为了了解线粒体功能障碍如何促进房性和室性心律失常事件,我们将
使用最先进的电子标测(EMAP)解剖空间特定的变化(心房和心室)
LAM实验室提供的心律失常Ndufs4-CKO心脏。空间转录和代谢组学分析
将使用靶向细胞和线粒体新陈代谢,可用于Lee实验室。通过将专业知识结合起来
电/钙信号转导(LAM实验室)和新陈代谢(Lee实验室),这一系列实验将提供
将线粒体功能障碍与心律失常联系起来的重要机制靶点有待进一步研究。我们的
长期目标是申请多PI R01拨款,分析详细的分子机制如何
线粒体代谢调节心律失常中的电/钙信号。我们的试点数据已经支持
可能的机制之一与线粒体改变NAD+依赖的代谢信号有关
功能障碍,使钙处理蛋白失控(如CaMKII乙酰化)。互补的专业知识
Lee和LAM实验室将在发展我们的年轻研究计划和
了解心律失常的新机制。
英文摘要
The goal of the parent COBRE award (P20GM139763) is to support research project leaders (RPL) to
scientific independence in area of cellular metabolism by creating and unifying resources under the COBRE-
supported Center of Cellular Metabolism Research in Oklahoma (CMRO). Dr. Chi Fung Lee has been
supported by the CMRO-COBRE as a RPL. The Lee lab has created a research program that investigates
how metabolism regulates heart disease progression. With the current COBRE support, the Lee lab is
examining mechanisms by which mitochondrial dysfunction and NAD+ redox imbalance promotes diabetic
cardiomyopathy. Patients with heart disease are associated with arrhythmias, which increase risks of patients
to heart failure, stroke and sudden death. In this supplement award, the Lee lab seeks support to continue a
collaboration with the Lam Lab at the University of Delaware on cardiac electrical/calcium signaling, and to
together examine the mechanistic roles of mitochondrial dysfunction and metabolism in arrhythmogenesis.
We aim to examine how mitochondrial metabolism regulates electrical/calcium signals to promote
arrhythmias, a hypothesis that has not been rigorously and directly tested. Dr. Chi Keung Lam was well-trained
in laboratories studying electrical/calcium signaling in mouse models and using induced pluripotent stem cell
platforms to identify mechanisms of arrhythmias. Our pilot data using cardiac-specific mitochondrial
dysfunction mice (Ndufs4-cKO) showed that mitochondrial dysfunction increases susceptibility of hearts to
arrhythmias and promotes sudden death. We found that calcium signaling is altered in cardiomyocytes isolated
from the arrhythmic Ndufs4-cKO hearts. In this supplement award, we plan to thoroughly characterize changes
in mitochondrial function and metabolism, and electrical/calcium signaling in these arrhythmias hearts.
To understand how mitochondrial dysfunction promotes atrial and ventricular arrhythmic events, we will
dissect spatial-specific changes (atrial and ventricular) using state-of-the-art electrical mapping (eMapping) of
the arrhythmic Ndufs4-cKO hearts available to the Lam lab. Spatial transcriptomic and metabolomic analyses
targeting cellular and mitochondrial metabolism will be used, available to the Lee lab. By coupling the expertise
of electrical/calcium signaling (Lam lab) and metabolism (Lee lab), this series of experiments will provide
important mechanistic targets to be further explored linking mitochondrial dysfunction to arrhythmias. Our
long-term goal is to apply for a multi-PIs R01 grant that dissects detailed molecular mechanisms how
mitochondrial metabolism regulates electrical/calcium signaling in arrhythmias. Our pilot data already support
one of the possible mechanisms in related to NAD+-dependent metabolic signaling altered by mitochondrial
dysfunction to deregulate calcium handling proteins (e.g. CaMKII acetylation). The complementary expertise
in the Lee and Lam labs will have synergistic effects in developing our young research programs and
understanding novel mechanisms of arrhythmias.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
SARM1 NAD Hydrolase Deficiency Normalizes Fibrosis and Ameliorates Cardiac Dysfunction in Diabetic Hearts.
SARM1 NAD 水解酶缺乏可使糖尿病心脏的纤维化正常化并改善心脏功能障碍。
DOI:
--
发表时间:
2022
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[Lee,ChiFung, Nizami,Hina, Gu,Haiwei, Light,Christine]
通讯作者:
Light,Christine
Sexually dimorphic effects of SARM1 deletion on cardiac NAD+ metabolism and function.
SARM1 缺失对心脏 NAD 代谢和功能的性别二态性影响。
DOI:
10.1152/ajpheart.00370.2022
发表时间:
2022
期刊:
American journal of physiology. Heart and circulatory physiology
影响因子:
--
作者:
[Nizami,HinaLateef, Minor,KeatonE, Chiao,YingAnn, Light,ChristineM, Lee,ChiFung]
通讯作者:
Lee,ChiFung
Center for Cellular Metabolism Research in Oklahoma
-
批准号:10797920
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Administrative Core
-
批准号:10090976
-
项目类别:
-
资助金额:$47.63万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Center for Cellular Metabolism Research in Oklahoma
-
批准号:10399960
-
项目类别:
-
资助金额:$23.05万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Center for Cellular Metabolism Research in Oklahoma
-
批准号:10571889
-
项目类别:
-
资助金额:$262.2万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Administrative Core
-
批准号:10571890
-
项目类别:
-
资助金额:$51.2万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Administrative Core
-
批准号:10339347
-
项目类别:
-
资助金额:$47.63万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Center for Cellular Metabolism Research in Oklahoma
-
批准号:10339346
-
项目类别:
-
资助金额:$262.2万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Center for Cellular Metabolism Research in Oklahoma
-
批准号:10090975
-
项目类别:
-
资助金额:$262.2万
-
财政年份:2021
-
负责人:Lijun Xia
-
依托单位:
Site-1 protease-mediated lipid metabolism in lymphatic vascular development
-
批准号:10400114
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Site-1 protease-mediated lipid metabolism in lymphatic vascular development
-
批准号:10629188
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Platelet CLEC-2 in Arterial Thrombosis
-
批准号:10652286
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Site-1 protease-mediated lipid metabolism in lymphatic vascular development
-
批准号:10219357
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Site-1 protease-mediated lipid metabolism in lymphatic vascular development
-
批准号:10033653
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Platelet CLEC-2 in Arterial Thrombosis
-
批准号:10052925
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Platelet CLEC-2 in Arterial Thrombosis
-
批准号:10434845
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Lijun Xia
-
依托单位:
Podoplanin-mediated platelet activation and vascular integrity in the developing brain
-
批准号:8862903
-
项目类别:
-
资助金额:$35.59万
-
财政年份:2015
-
负责人:Lijun Xia
-
依托单位:
Podoplanin-mediated platelet activation and vascular integrity in the developing brain
-
批准号:9122443
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2015
-
负责人:Lijun Xia
-
依托单位:
PODOPLANIN REGULATION OF LYMPHATIC ENDOTHELIAL CELL IDENTITY IN VIVO
-
批准号:8364978
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2011
-
负责人:Lijun Xia
-
依托单位:
COBRE: OK MED RES FOUND: CORE II: INTRAVITAL MICROSCOPE CORE FACILITY
-
批准号:8168455
-
项目类别:
-
资助金额:$8.97万
-
财政年份:2010
-
负责人:Lijun Xia
-
依托单位:
Role of Mucin-type O-glycans in Intestinal Inflammation
-
批准号:8117759
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2010
-
负责人:Lijun Xia
-
依托单位:
海外基金